The International Partnership for Microbicides

		English \| French \| Spanish 2008 \| 2007 \| 2006 \| 2005 \| 2004 \| 2003
2008
March 11
		Microbicide Developer Receives License for Novel HIV Microbicide Candidate from Merck & Co., Inc.

February 19
		Zeda Rosenberg Statement on Carraguard PRO 2000 Microbicide Trials

January 30
		IPM and Pfizer Agree to Develop FDA Approved Antiretroviral Drug Maraviroc as a Vaginal Microbicide

2007
March 8
		Statement on International Women’s Day

March 1
		ImQuest Pharmaceuticals Receives Grant from International Partnership for Microbicides to Develop Novel Microbicide

January 31
		Statement on the Closing of Cellulose Sulfate Gel Trials Due to Concerns of Potential Increased Risk of HIV Infection

January 29
		EC Commits €4.2 million to Microbicide Development

2006
December 15
		Statement on Findings that Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV
December 11
		Gilead Grants Intellectual Property Rights for Tenofovir Topical Gel to the International Partnership for Microbicides and CONRAD
December 1
		Canada Commits CAD15 Million to Accelerate Microbicide Development on World AIDS Day
		Belgium Pledges €3 Million to HIV Prevention for Women
November 20
		IPM Lauds the Netherlands for Renewed Commitment to Developing Tools to Protect Women from HIV
August 13
		Consultation on Microbicide Introduction in Africa and India Successfully Concluded Today
March 8
		International Women’s Day
2005
December 1
		Nearly US$30 Million Committed to Microbicide Development
November 21
		Drug Company Support is Critical to Advancing AIDS Prevention Effort: Statement by IPM CEO, Dr. Zeda Rosenberg, on New AIDS Statistics
October 31
		Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV
October 12
		Arizona Health Leaders Gather in Tucson to Discuss New Methods for Protecting Women from HIV
August 4
		Leading Microbicide Developers Announce Research and Development Partnership to Create New HIV-Prevention Technology for Women
July 8
		UK Release - Global Health Leaders React to G8’s First-Ever Call for More Investment in Microbicides to Protect Women from HIV
		US Release - Global Health Leaders React to G8’s First-Ever Call for More Investment in Microbicides to Protect Women from HIV
		Candian Release - Global Health Leaders React to G8’s First-Ever Call for More Investment in Microbicides to Protect Women from HIV
		German Release - Global Health Leaders React to G8’s First-Ever Call for More Investment in Microbicides to Protect Women from HIV
		French Release - Global Health Leaders React to G8’s First-Ever Call for More Investment in Microbicides to Protect Women from HIV
June 2
		Call for World Leaders to Redouble Efforts to Develop Vaccines and Microbicides to Prevent HIV
May 30
		African Leaders Meet International Health Officials to Discuss Microbicides to Protect Women from HIV
April 5
		IPM Lauds UK Government for Microbicide Support Statement by IPM CEO, Zeda Rosenberg
March 17
		IPM Growth Leads to Expanded Scientific Unit
		State-of-the-Art Manufacturing Facility Launched to Produce Microbicides to Protect Women from HIV
March 4
		IPM Appoints New Board Members and New Chair and Vice-Chair

2004
December 1
		World AIDS Day: Women and Girls, HIV and AIDS
		IPM Hails CAD $15 Million to Support Microbicide Research and Development to Protect Women Against HIV
November 24
		U.S. Foreign Aid Spending Bill And Includes $8 Million Increase For Microbicide Development
November 23
		World Aids Day - Statement by IPM CEO on New AIDS Statistics
September 24
		IPM enters into a Preliminary Agreement with GlaxoSmithKline to explore Potential of Anti-HIV Compounds as Microbicides
September 16
		Senate Appropriations Committee Passes FY ‘05 Foreign Aid Spending Bill And Includes $32 Million For Microbicide Development
July 15
		IPM CEO Calls for Global Investment in Microbicide That Could Avert Nearly 1 Million HIV Infections a Year
June 24
		New Options Needed to Prevent the Spread of HIV/AIDS
March 29
		IPM will Take Over the Development of Tibotec’s Promising Microbicide to Help in the Prevention of the Sexual Transmission of HIV
March 16
		Health Canada Official to join IPM, a global partnership developing microbicides to protect women against HIV

2003
May 13
		IPM Hails Global HIV Prevention Working Group's Call for $1 Billion in Additional Public Sector Spending on Microbicide R & D
March 31
		Gates Foundation makes $60 million grant to accelerate HIV/AIDS microbicide research